ODENZA CORP
ODENZA CORP operates in various business sectors.
ODENZA CORP (ODZA) - Net Assets
Latest net assets as of January 2024: $-41.20K USD
Based on the latest financial reports, ODENZA CORP (ODZA) has net assets worth $-41.20K USD as of January 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($915.00) and total liabilities ($42.11K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-41.20K |
| % of Total Assets | -4502.51% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ODENZA CORP - Net Assets Trend (2011–2024)
This chart illustrates how ODENZA CORP's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ODENZA CORP (2011–2024)
The table below shows the annual net assets of ODENZA CORP from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-01-31 | $-36.68K | +16.77% |
| 2023-01-31 | $-44.07K | +83.13% |
| 2021-01-31 | $-261.31K | -15.31% |
| 2020-01-31 | $-226.62K | -22.68% |
| 2018-01-31 | $-184.72K | -292.58% |
| 2012-01-31 | $-47.05K | -2334.25% |
| 2011-01-31 | $-1.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to ODENZA CORP's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 34631400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $343.06K | % |
| Total Equity | $-36.68K | 100.00% |
ODENZA CORP Competitors by Market Cap
The table below lists competitors of ODENZA CORP ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SRPU
BATS:SRPU
|
$83.47K |
|
CLARIANT N
MU:CLRN
|
$83.48K |
|
EYDAP (EYP.SG)
STU:EYP
|
$83.49K |
|
CSMG3F
SA:CSMG3F
|
$83.59K |
|
SUZB3F
SA:SUZB3F
|
$83.41K |
|
THE WESTERN UNION - Dusseldorf Stock Exchang
DU:W3U
|
$83.41K |
|
CLP HLDGS
MU:CLP
|
$83.38K |
|
MRWNS
OTCGREY:MRWNS
|
$83.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ODENZA CORP's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -44,072 to -36,682, a change of 7,390.
- Net loss of 29,283 reduced equity.
- Other factors increased equity by 36,673.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-29.28K | -79.83% |
| Other Changes | $36.67K | +99.98% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares ODENZA CORP's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-01-31 | $-0.03 | $8.50 | x |
| 2012-01-31 | $-0.64 | $8.50 | x |
| 2013-01-31 | $-1.00 | $8.50 | x |
| 2014-01-31 | $-1.33 | $8.50 | x |
| 2015-01-31 | $-1.54 | $8.50 | x |
| 2016-01-31 | $-1.76 | $8.50 | x |
| 2017-01-31 | $-2.01 | $8.50 | x |
| 2018-01-31 | $-2.52 | $8.50 | x |
| 2019-01-31 | $-2.84 | $8.50 | x |
| 2020-01-31 | $-3.10 | $8.50 | x |
| 2021-01-31 | $-3.57 | $8.50 | x |
| 2023-01-31 | $-0.60 | $8.50 | x |
| 2024-01-31 | $-0.50 | $8.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ODENZA CORP utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.18K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-40.42K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.11K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.95K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.09K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.27K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.61K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.28K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.18K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $3.71K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.56K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-35.92K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.61K |
Industry Comparison
This section compares ODENZA CORP's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $21,537,541,042
- Average return on equity (ROE) among peers: 11.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ODENZA CORP (ODZA) | $-41.20K | 0.00% | N/A | $83.44K |
| Arçelik Anonim Sirketi (ACKAF) | $6.92 Billion | 12.19% | 1.96x | $21.37K |
| Argo Group US Inc. 6.5% SR NTS 42 (ARGD) | $1.78 Billion | -0.47% | 4.90x | $237.80K |
| American Crystal Sugar Company PFD REST NON DIV (ASCS) | $350.39 Million | 158.73% | 1.79x | $54.40 Million |
| Autobacs Seven Co. Ltd (ATBSF) | $138.55 Billion | 3.33% | 0.35x | $167.34K |
| Brookfield Asset Management Inc FR PRF PERPETUAL CAD 25 Ser 2 Cls A (BKFAF) | $45.44 Billion | 2.81% | 1.39x | $78.15K |
| Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) | $14.42 Billion | 11.26% | 1.20x | $9.29 Million |
| BOL Bancshares Inc. PFD (BOLBP) | $11.94 Million | 0.62% | 6.68x | $0.94 |
| NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) | $3.35 Billion | 13.98% | 0.95x | $246.38K |
| Canadian Utilities Limited 2ND PFD SER Y (CNAUF) | $4.37 Billion | 11.86% | 2.07x | $137.52K |
| Central Parking Finance Trust PFD TR CV SECS (CRLKP) | $181.00 Million | -95.58% | 5.28x | $220.55K |